PropertyValue
?:definition
  • Substances designed to substitute the hemostasis capability of platelets of human blood without associated thrombogenicity. There are several types of compounds intended for platelet substitutes, including: (1) infusible platelet membranes produced from human platelets, (2) fibrinogen-coated albumin microspheres, and (3) liposome-based agents. Platelet blood substitutes are intended to increase in-vivo hemostasis for a significant period of time.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4052713_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4052713_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all